{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:38:06Z","timestamp":1777293486223,"version":"3.51.4"},"reference-count":64,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2021.10955","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T08:23:14Z","timestamp":1636446194000},"source":"Crossref","is-referenced-by-count":6,"title":["Morphological classification and changes in dementia (Review)"],"prefix":"10.3892","volume":"23","author":[{"given":"Alexandra","family":"Tudor","sequence":"first","affiliation":[{"name":"Department of Psychiatry, \u2018Prof. Dr. Alex. Obregia\u2019 Clinical Hospital of Psychiatry, 041914 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Vasile","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Medical Military Institute, 010919 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Trifu","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Cristea","sequence":"additional","affiliation":[{"name":"Department of Morphological Sciences, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"key":"key20220302121048_b1-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/B978-0-12-802973-2.00008-2","article-title":"Dementias","volume":"138","author":"Sacuiu","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"key20220302121048_b2-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/jcbfm.2015.164","article-title":"The neuropathology and cerebrovascular mechanisms of dementia","volume":"36","author":"Raz","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"key20220302121048_b3-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neures.2018.08.005","article-title":"Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors","volume":"141","author":"Takeda","year":"2019","journal-title":"Neurosci Res"},{"key":"key20220302121048_b4-ETM-0-0-10955","first-page":"4","article-title":"Frontotemporal dementia, Pick's disease","volume":"63","author":"Kertesz","year":"2010","journal-title":"Ideggyogy Sz"},{"key":"key20220302121048_b5-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/CON.0000000000000309","article-title":"Lewy body dementias: Dementia with Lewy bodies and Parkinson disease Dementia","volume":"22 (2 Dementia)","author":"Gomperts","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"key20220302121048_b6-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1093\/brain\/aww243","article-title":"Whole-brain analysis reveals increased neuroanatomical asymmetries in dementia for hippocampus and amygdala","volume":"139","author":"Wachinger","year":"2016","journal-title":"Brain"},{"key":"key20220302121048_b7-ETM-0-0-10955","doi-asserted-by":"crossref","first-page":"986","DOI":"10.15405\/epsbs.2017.10.94","article-title":"Alcohol as a substitute, mask of depression and \u2018antidote\u2019 of narcissism","volume":"31","author":"Trifu","year":"2017","journal-title":"Eur Proc Soc Behav Sci"},{"key":"key20220302121048_b8-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/brain\/awu040","article-title":"Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia","volume":"137","author":"Barker","year":"2014","journal-title":"Brain"},{"key":"key20220302121048_b9-ETM-0-0-10955","doi-asserted-by":"crossref","first-page":"101","DOI":"10.12988\/asb.2017.737","article-title":"Morphologic changes in vascular dementia","volume":"9","author":"Kolomiytsev","year":"2017","journal-title":"Adv Stud Biol"},{"key":"key20220302121048_b10-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.3892\/etm.2020.8974","article-title":"Aggressive behavior in psychiatric patients in relation to hormonal imbalance (Review)","volume":"20","author":"Trifu","year":"2020","journal-title":"Exp Ther Med"},{"key":"key20220302121048_b11-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/bpa.12218","article-title":"White matter changes in dementia: Role of impaired drainage of interstitial fluid","volume":"25","author":"Weller","year":"2015","journal-title":"Brain Pathol"},{"key":"key20220302121048_b12-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1159\/000049150","article-title":"Small vessel disease and Alzheimer's dementia: Pathological considerations","volume":"13 (Suppl 2)","author":"Kalaria","year":"2002","journal-title":"Cerebrovasc Dis"},{"key":"key20220302121048_b13-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jns.2007.01.045","article-title":"Neuropathological evaluation of mixed dementia","volume":"257","author":"Jellinger","year":"2007","journal-title":"J Neurol Sci"},{"issue":"840","key":"key20220302121048_b14-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10110840","article-title":"Clozapine: An updated overview of pharmacogenetic biomarkers, risks, and safety-particularities in the context of COVID-19","volume":"10","author":"Dragoi","year":"2020","journal-title":"Brain Sci"},{"key":"key20220302121048_b15-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1242\/jcs.01558","article-title":"Tau phosphorylation in neuronal cell function and dysfunction","volume":"117","author":"Johnson","year":"2004","journal-title":"J Cell Sci"},{"issue":"8948","key":"key20220302121048_b16-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21238948","article-title":"Tauopathies: Deciphering disease mechanisms to develop effective therapies","volume":"21","author":"Silva","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20220302121048_b17-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jns.2004.09.019","article-title":"Towards defining the neuropathological substrates of vascular dementia","volume":"226","author":"Kalaria","year":"2004","journal-title":"J Neurol Sci"},{"key":"key20220302121048_b18-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neuro.2015.12.002","article-title":"Low levels of aluminum can lead to behavioral and morphological changes associated with Alzheimer's disease and age-related neurodegeneration","volume":"52","author":"Bondy","year":"2016","journal-title":"Neurotoxicology"},{"key":"key20220302121048_b19-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"key20220302121048_b20-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","article-title":"Vascular dementia","volume":"386","author":"O'Brien","year":"2015","journal-title":"Lancet"},{"key":"key20220302121048_b21-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ana.21296","article-title":"Neuropathological basis of magnetic resonance images in aging and dementia","volume":"63","author":"Jagust","year":"2008","journal-title":"Ann Neurol"},{"key":"key20220302121048_b22-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1212\/01.wnl.0000118211.78503.f5","article-title":"Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology","volume":"62","author":"Schneider","year":"2004","journal-title":"Neurology"},{"issue":"31","key":"key20220302121048_b23-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt93","article-title":"Amyloid imaging in the differential diagnosis of dementia: Review and potential clinical applications","volume":"3","author":"Laforce","year":"2011","journal-title":"Alzheimers Res Ther"},{"key":"key20220302121048_b24-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1212\/wnl.55.4.484","article-title":"Rates of hippocampal atrophy correlate with change in clinical status in aging and AD","volume":"55","author":"Jack","year":"2000","journal-title":"Neurology"},{"key":"key20220302121048_b25-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/brain\/120.6.1027","article-title":"The temporal variant of frontotemporal dementia","volume":"120","author":"Edwards-Lee","year":"1997","journal-title":"Brain"},{"issue":"274","key":"key20220302121048_b26-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00274","article-title":"Specific patterns of white matter alterations help distinguishing Alzheimer's and vascular dementia","volume":"12","author":"Palesi","year":"2018","journal-title":"Front Neurosci"},{"key":"key20220302121048_b27-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/gerona\/63.7.764","article-title":"Cholinergic deficiency hypothesis in delirium: A synthesis of current evidence","volume":"63","author":"Hshieh","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key20220302121048_b28-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1503\/jpn.110190","article-title":"Glutamate system, amyloid \u03b2 peptides and tau protein: Functional interrelationships and relevance to Alzheimer disease pathology","volume":"38","author":"Revett","year":"2013","journal-title":"J Psychiatry Neurosci"},{"key":"key20220302121048_b29-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0011-393X(03)00059-6","article-title":"Cholinesterase inhibitors for the treatment of Alzheimer's disease: Getting on and staying on","volume":"64","author":"Grossberg","year":"2003","journal-title":"Curr Ther Res Clin Exp"},{"key":"key20220302121048_b30-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1755-5949.2010.00166.x","article-title":"Effects of cholinesterase inhibitors in Parkinson's disease dementia: A review of clinical data","volume":"17","author":"van Laar","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"key20220302121048_b31-ETM-0-0-10955","first-page":"884","article-title":"Clinical practice guidelines and principles of care for people with dementia in Australia","volume":"45","author":"Dyer","year":"2016","journal-title":"Aust Fam Physician"},{"key":"key20220302121048_b32-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/s0317167100015183","article-title":"4th canadian consensus conference on the diagnosis and treatment of dementia","volume":"39 (Suppl 5)","author":"Gauthier","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"key20220302121048_b33-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: Pharmacology and toxicology","volume":"11","author":"Colovi\u0107","year":"2013","journal-title":"Curr Neuropharmacol"},{"issue":"CD003154","key":"key20220302121048_b34-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003154.pub6","article-title":"Memantine for dementia","volume":"3","author":"McShane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"key20220302121048_b35-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"v53","DOI":"10.1136\/jnnp.2004.052332","article-title":"Treatment of dementia","volume":"76 (Suppl 5)","author":"Overshott","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20220302121048_b36-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer's disease: An appraisal from 1984 to 2014","volume":"275","author":"Schneider","year":"2014","journal-title":"J Intern Med"},{"key":"key20220302121048_b37-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1527-3458.2002.tb00221.x","article-title":"Galantamine-a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease","volume":"8","author":"Lilienfeld","year":"2002","journal-title":"CNS Drug Rev"},{"issue":"14","key":"key20220302121048_b38-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-015-0014-7","article-title":"Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia","volume":"1","author":"Hashiguchi","year":"2015","journal-title":"J Pharm Health Care Sci"},{"issue":"e0222505","key":"key20220302121048_b39-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222505","article-title":"Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer's disease mortality","volume":"14","author":"Benito-Le\u00f3n","year":"2019","journal-title":"PLoS One"},{"issue":"CD002854","key":"key20220302121048_b40-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002854.pub5","article-title":"Vitamin E for Alzheimer's dementia and mild cognitive impairment","volume":"1","author":"Farina","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"key20220302121048_b41-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"key":"key20220302121048_b42-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41575-020-0339-z","article-title":"Parkinson disease and the gut: New insights into pathogenesis and clinical relevance","volume":"17","author":"Travagli","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"e13031","key":"key20220302121048_b43-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"key20220302121048_b44-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/brain\/awu057","article-title":"Accumulation of oligomer-prone \u03b1-synuclein exacerbates synaptic and neuronal degeneration in vivo","volume":"137","author":"Rockenstein","year":"2014","journal-title":"Brain"},{"issue":"a009399","key":"key20220302121048_b45-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-Synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"88","key":"key20220302121048_b46-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2012.00088","article-title":"Cognitive impairment and dementia in Parkinson's disease: Clinical features, diagnosis, and management","volume":"3","author":"Meireles","year":"2012","journal-title":"Front Neurol"},{"key":"key20220302121048_b47-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.18034","article-title":"Abnormal eye movements in parkinsonism and movement disorders","volume":"12","author":"Jung","year":"2019","journal-title":"J Mov Disord"},{"issue":"63","key":"key20220302121048_b48-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0816-4","article-title":"Effects of antidepressants on sleep","volume":"19","author":"Wichniak","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"key20220302121048_b49-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1600-0404.1976.tb04375.x","article-title":"Dementia in Parkinson's disease","volume":"54","author":"Martilla","year":"1976","journal-title":"Arch Neurol Scand"},{"key":"key20220302121048_b50-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.4103\/0972-2327.83083","article-title":"Parkinson's disease","volume":"14 (Suppl 1)","author":"Behari","year":"2011","journal-title":"Ann Indian Acad Neurol"},{"issue":"fcaa172","key":"key20220302121048_b51-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa172","article-title":"Longitudinal expression changes are weak correlates of disease progression in Huntington's disease","volume":"2","author":"Mitchell","year":"2020","journal-title":"Brain Commun"},{"key":"key20220302121048_b52-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/braincomms\/fcaa172","article-title":"New directions in therapeutics for Huntington disease","volume":"13","author":"Potkin","year":"2018","journal-title":"Future Neurol"},{"issue":"135","key":"key20220302121048_b53-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2014.00135","article-title":"Mood disorders in Huntington's disease: From behavior to cellular and molecular mechanisms","volume":"8","author":"Pla","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"key20220302121048_b54-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0010-9452(86)80030-2","article-title":"An assessment of verbal recall, recognition and fluency abilities in patients with Huntington's disease","volume":"22","author":"Butters","year":"1986","journal-title":"Cortex"},{"key":"key20220302121048_b55-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1037\/\/0894-4105.13.3.381","article-title":"The disparate effects of Alzheimer's disease and Huntington's disease on semantic memory","volume":"13","author":"Rohrer","year":"1999","journal-title":"Neuropsychology"},{"key":"key20220302121048_b56-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1037\/tps0000124","article-title":"Alterations in hippocampal activity and Alzheimer's disease","volume":"3","author":"Setti","year":"2017","journal-title":"Transl Issues Psychol Sci"},{"issue":"2398212817701448","key":"key20220302121048_b57-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.1177\/2398212817701448","article-title":"Segmenting subregions of the human hippocampus on structural magnetic resonance image scans: An illustrated tutorial","volume":"1","author":"Dalton","year":"2017","journal-title":"Brain Neurosci Adv"},{"issue":"266","key":"key20220302121048_b58-ETM-0-0-10955","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00266","article-title":"Hippocampal deficits in amyloid-\u03b2-related rodent models of Alzheimer's disease","volume":"14","author":"Vyas","year":"2020","journal-title":"Front Neurosci"},{"key":"key20220302121048_b59-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.neurobiolaging.2003.12.007","article-title":"MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD","volume":"25","author":"deToledo-Morrell","year":"2004","journal-title":"Neurobiol Aging"},{"key":"key20220302121048_b60-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00401-016-1562-0","article-title":"Granulovacuolar degeneration: A neurodegenerative change that accompanies tau pathology","volume":"132","author":"K\u00f6hler","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key20220302121048_b61-ETM-0-0-10955","first-page":"10","article-title":"Hirano bodies and Alzheimer's disease","volume":"13","author":"Mitake","year":"1997","journal-title":"Kaohsiung J Med Sci"},{"key":"key20220302121048_b62-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0169-328x(97)00192-7","article-title":"Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus","volume":"49","author":"Connor","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"key20220302121048_b63-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0169-328x(97)00125-3","article-title":"Brain-derived neurotrophic factor is reduced in Alzheimer's disease","volume":"49","author":"Connor","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"key20220302121048_b64-ETM-0-0-10955","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neuropharm.2018.01.008","article-title":"Evidence for altered insulin receptor signaling in Alzheimer's disease","volume":"136","author":"Griffith","year":"2018","journal-title":"Neuropharmacology"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T10:14:17Z","timestamp":1646216057000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2021.10955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,11,9]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2021.10955","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,9]]},"article-number":"33"}}